Leaders of the world’s seven most industrialised countries recognise the need to increase the production and availability of anti-Covid-19 medical products in low and middle income countries.
Aware of the “importance of intellectual property in this regard”, they promise to engage “constructively” in the WTO talks while remaining within the framework of the TRIPS Agreement, in the declaration they adopted on Sunday 13 June.
But the G7 does not advocate lifting patents on...